Atricure Inc. buy Needham & Company LLC
Start price
29.11.23
/
50%
€33.20
Target price
29.11.24
€44.64
Performance (%)
-
End price
30.11.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | -1.775% | -1.775% | -46.452% |
| iShares Core DAX® | 2.032% | 3.499% | 24.306% |
| iShares Nasdaq 100 | -0.145% | -1.849% | 5.004% |
| iShares Nikkei 225® | 4.507% | 1.976% | 16.735% |
| iShares S&P 500 | 0.331% | -0.103% | 3.168% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $49.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten